Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low- and middle-income countries

MLA

Vininta Fazharyasti, et al. “Convalescent Plasma Therapy in Patients with Moderate-to-Severe COVID-19: A Study from Indonesia for Clinical Research in Low- and Middle-Income Countries.” EClinicalMedicine, vol. 36, June 2021, p. 100931. EBSCOhost, https://doi.org/10.1016/j.eclinm.2021.100931.

APA

Vininta Fazharyasti, David H. Muljono, Frilasita A. Yudhaputri, Marliana S. Rejeki, Nana Sarnadi, Wisvici Y. Samin, Edison Johar, Novilia S. Bachtiar, Neni Nurainy, & Retno Wihastuti. (2021). Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low- and middle-income countries. EClinicalMedicine, 36, 100931. https://doi.org/10.1016/j.eclinm.2021.100931

Chicago

Vininta Fazharyasti, David H. Muljono, Frilasita A. Yudhaputri, Marliana S. Rejeki, Nana Sarnadi, Wisvici Y. Samin, Edison Johar, Novilia S. Bachtiar, Neni Nurainy, and Retno Wihastuti. 2021. “Convalescent Plasma Therapy in Patients with Moderate-to-Severe COVID-19: A Study from Indonesia for Clinical Research in Low- and Middle-Income Countries.” EClinicalMedicine 36 (June): 100931. doi:10.1016/j.eclinm.2021.100931.